Evaluation of Initiation Time on the Efficacy of Gabapentin in Treating Neuropathic Pain in SCI
Status:
Completed
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
Neuropathic pain is a common complaint in those with spinal cord injury (SCI) that has a
significant negative effect on quality of life. Efficacy of various treatments, however,
remains controversial. There is evidence to support that gabapentin and pregabalin have some
benefit in reducing neuropathic pain. Gabapentin is effective in the management of symptoms
and concerns related to SCI including motor recovery, spasticity, and mood among others. This
makes gabapentin an important pharmacologic intervention, which compels providers to define
treatment guidelines related to its use. One aspect of which should relate to the timing of
initiation of therapy. The goal of this study is to determine whether timing of initiation of
treatment with gabapentin will decrease prevalence and intensity of neuropathic pain.